Expert: Device makers should assess reimbursement early

01/27/2010 | Clinica (subscription required)

Medical-device makers should assess the potential reimbursement rates of products at the early stage of the development process, writes John Avellanet, Cerulean Associates' managing director. Evaluating the reimbursement implications early on could help companies to determine the profitability of a product before it reaches the market, Avellanet said.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ